HDA Survey Offers Some Troubling DSCSA Prep Results – HealthcarePackaging.com

According to the article, "With just two years left to meet the Nov. 2023 DSCSA requirements, a readiness survey shows that there is much work to be done in drug supply chain traceability. 57% of manufacturers surveyed have no successful data connections in production environments."

Read More

Are You Prepared For The U.S. Enhanced Drug Distribution Security (EDDS) Requirements? – BioProcess Online

EDDS will be enabled by the establishment of standards for the interoperable exchange of data, combined with the inclusion of individual serial numbers in the product shipment transaction information transmitted for the NDCs/Lot #s sold and distributed.

Read More

Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights

California Designated Representative Training – for wholesalers or 3PL According to the article: “Blockchain startup Mediledger has published the results of its FDA blockchain pilot for the pharmaceutical supply chain. Numerous separate groups applied to the FDA and ran pilots for the Drug Supply Chain Security Act (DSCSA) 2023 milestone for package-level tracing, with this […]

Read More

Here comes drug importation – Pharmaceutical Commerce

3 distinct Board-approved California Designated Representative online training classes for wholesalers, 3PL, reverse distributors. Earns a training affidavit. According to the article: “The Trump Administration wants to start a drug-importation program from Canada for both small-molecule and biologic products. The program would be a “time-limited Section 804 importation program” (SIP), with the SIP program sponsored […]

Read More
TOP